The 2-Minute Rule for pharmaceutical ingredients and excipients
A documented, on-going screening program should be recognized to monitor the stability characteristics of APIs, and the final results must be employed to confirm appropriate storage circumstances and retest or expiry dates.Ideal GMP concepts should be applied during the manufacture of APIs for use in clinical trials with an appropriate system for a